A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes
Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Jan 27, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to compare two types of surgical procedures for women with certain benign (non-cancerous) conditions affecting the uterus, such as fibroids and abnormal bleeding. The study will look at the long-term effects of total laparoscopic hysterectomy (removing the entire uterus) versus subtotal laparoscopic hysterectomy (removing only part of the uterus) along with a small incision for extracting the uterus. Researchers aim to see how these surgeries impact patients' quality of life three years after the operation, as well as their experiences regarding pain, recovery time, and any complications.
To be eligible for this trial, participants should be women over 18 years old who can provide informed consent. However, some women may not qualify, including those with suspected cancers or certain medical conditions, those who are pregnant, or those who wish to have more children in the future. Participants will fill out questionnaires before and after the surgery, which will help assess their health and satisfaction with the surgery. This trial is not yet recruiting, so there’s still time to learn more before deciding to participate.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age\>18 years
- • Signed informed consent
- Exclusion Criteria:
- • Uterine or adnexal pathology suspect for malignancy
- • Abnormal or unknown PAP test
- • Patients with invasive neoplasia in the previous 5 years (excluding non-melanoma skin tumors, breast cancer T1 N0 M0 Grade 1 or 2 without signs of recurrence or activity).
- • Previous radical pelvic surgery or radiotherapy;
- • Age \> 80 years
- • Pregnant patients
- • Desire for further pregnancies
- • Contraindications to general anaesthesia or to the Trendelenburg position
- • Refusal to sign informed consent
About Fondazione Policlinico Universitario Agostino Gemelli Irccs
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Roma, Lazio, Italy
Patients applied
Trial Officials
Giovanni Panico, MD
Principal Investigator
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported